Steroids in the treatment of group A streptococcal necrotizing soft tissue infection

Surgical Infections

Volumn 12, Issue 1, 2011, Pages 77-81

  May, Addison K ^a   Daniels, Titus L ^a   Obremskey, William T ^a   Kaiser, Allen B ^a   Talbot, Thomas R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; DROTRECOGIN; FRESH FROZEN PLASMA; GLUCOCORTICOID; HUMAN IMMUNOGLOBULIN; HYDROCORTISONE; INFUSION FLUID; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DISSEMINATED INTRAVASCULAR CLOTTING; ECCHYMOSIS; ERYTHEMA; FLUID RESUSCITATION; GROUP A STREPTOCOCCAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MALE; MENINGITIS; PRIORITY JOURNAL; SEPTIC SHOCK; SKIN EXAMINATION; SOFT TISSUE INFECTION; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME;

ANTI-INFLAMMATORY AGENTS; FASCIITIS, NECROTIZING; HUMANS; MALE; MIDDLE AGED; SHOCK, SEPTIC; STEROIDS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 79951529029     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2010.035     Document Type: Article

References (14)

1. Stevens DL. Streptococcal toxic-shock syndrome: Spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995;1:69-78.
2. Lappin E, Ferguson AJ. Gram-positive toxic shock syndromes. Lancet Infect Dis 2009;9:281-290.
3. May AK, Stafford RE, Bulger EM, et al. Treatment of complicated skin and soft tissue infections. Surg Infect 2009;10: 467-499.
4. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:1373-1406. (Pubitemid 41581713)
5. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999;20:250-278.
6. Pahlman LI, Olin AI, Darenberg J, et al. Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation. Cell Microbiol 2008;10:404-414.
7. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008;36:1937-1949.
8. Marik PE. Critical illness-related corticosteroid insufficiency. Chest 2009;135:181-193.
9. Alwattar BJ, Strongwater A, Sala DA. Streptococcal toxic shock syndrome presenting as septic knee arthritis in a 5-year-old child. J Pediatr Orthop 2008;28:124-127. (Pubitemid 351628201)
10. Chiu CH, Ou JT, Chang KS, Lin TY. Successful treatment of severe streptococcal toxic shock syndrome with a combination of intravenous immunoglobulin, dexamethasone and antibiotics. Infection 1997;25:47-48. (Pubitemid 27075661)
11. Shoji F, Yoshino I, Osoegawa A, et al. Toxic shock syndrome following thoracic surgery for lung cancer: Report of a case. Surg Today 2007;37:587-589. (Pubitemid 46998954)
12. Stegmayr B, Bjorck S, Holm S, et al. Septic shock induced by group A streptococcal infection: Clinical and therapeutic aspects. Scand J Infect Dis 1992;24:589-597.
13. Beek BD van de, Gans J de, McIntyre P, Prasad K. Corti-costeroids for acute bacterial meningitis. Cochrane Database Syst Rev 2007;CD004405.
14. Almawi WY, Beyhum HN, Rahme AA, Rieder MJ. Regulation of cytokine and cytokine receptor expression by gluco-corticoids. J Leukocyte Biol 1996;60:563-572. (Pubitemid 26400412)